Kawarada Osami, Yasuda Satoshi, Noguchi Teruo, Anzai Toshihisa, Ogawa Hisao
Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, 5-7-1 Fujishiro-dai, Suita, Osaka, 565-8565, Japan.
Cardiovasc Interv Ther. 2016 Jul;31(3):171-82. doi: 10.1007/s12928-016-0392-2. Epub 2016 Apr 6.
Atherosclerotic renal artery disease presents with a broad spectrum of clinical features, including heart failure as well as hypertension, and renal failure. Although recent randomized controlled trials failed to demonstrate renal artery stenting can reduce blood pressure or the number of cardiovascular or renal events more so than medical therapy, increasing attention has been paid to flash pulmonary edema and congestive heart failure associated with atherosclerotic renal artery disease. This clinical entity "renovascular heart failure" is diagnosed retrospectively. Given the increasing global burden of heart failure, this review highlights the background and catheter-based therapeutic aspects for renovascular heart failure.
动脉粥样硬化性肾动脉疾病具有广泛的临床特征，包括心力衰竭、高血压以及肾衰竭。尽管近期的随机对照试验未能证明肾动脉支架置入术比药物治疗更能降低血压或减少心血管或肾脏事件的发生数量，但与动脉粥样硬化性肾动脉疾病相关的急性肺水肿和充血性心力衰竭已受到越来越多的关注。这种临床实体“肾血管性心力衰竭”是通过回顾性诊断的。鉴于全球心力衰竭负担日益加重，本综述重点介绍了肾血管性心力衰竭的背景及基于导管的治疗方面。
